Samsara BioCapital Portfolio 2026

12 companies backed by Samsara BioCapital, including Normunity, Jade Biosciences, Ottimo Pharma. Each links to its full verified cap-table syndicate.

Samsara Biocapital accounts for 3 tracked companies with verified cap-table data, 3 of which disclose round sizes totalling $407M. The median disclosed raise is $61M, and the largest is FogPharma at $323M, ahead of MiroBio ($61M) and Primmune Therapeutics ($23M).

The names that recur most often on these portfolio cap tables are Samsara Biocapital (3 companies), ARCH Venture Partners (1 company), Milky Way Investments (1 company), Fidelity Management & Research Company (1 company), Nextech Invest (1 company), RA Capital Management (1 company). By latest disclosed round, the market skews Series D (1), Series A (1), Series B (1).

Best funded Samsara Biocapital companies

  1. FogPharma — $323M (latest: Series D)
  2. MiroBio — $61M (latest: Series A)
  3. Primmune Therapeutics — $23M (latest: Series B)

Samsara Biocapital — related firms and companies (47)

Samsara Biocapital alternatives · All research reports